Pharmaceuticals News and Research

RSS

Auxogyn signs exclusive license agreement with Merck Serono for Eeva Test

Auxogyn, Inc., a company dedicated to advancing women's reproductive health, today announced an exclusive license agreement with Merck Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany which operates as EMD Serono in the United States and Canada, for Auxogyn's proprietary Early Embryo Viability Assessment (Eeva) Test.

3 Apr 2014

Europe's pharmaceutical research community to convene at PRO & eCOA Congress

The most progressive minds in Europe's pharmaceutical research community will convene at the PRO & eCOA Congress, Europe 3-5 June in Barcelona, Spain.

3 Apr 2014

BIO and WLSA to explore intersection between digital health and biotechnology at 2014 BIO International Convention

The Biotechnology Industry Organization (BIO) and the Wireless-Life Sciences Alliance (WLSA) today announced a partnership to explore the intersection between digital health and biotechnology through the inaugural Digital Health Zone and Forum at the 2014 BIO International Convention®.

3 Apr 2014

Gilead reports topline results from sofosbuvir Phase 3 trial in Japan for treatment of HCV infection

Gilead Sciences, Inc. today announced topline results from a Phase 3 clinical trial (Study GS-US-334-0118) in Japan evaluating the once-daily nucleotide analog polymerase inhibitor sofosbuvir in combination with ribavirin (RBV) for the treatment of genotype 2 chronic hepatitis C virus (HCV) infection.

3 Apr 2014

FDA grants Fast Track designations for IV and oral formulations of Tetraphase's eravacycline

Tetraphase Pharmaceuticals, Inc. today announced that the U.S. Food & Drug Administration has granted Fast Track designations for both the intravenous (IV) and oral formulations of the company's lead antibiotic candidate, eravacycline.

3 Apr 2014

Sanaria receives 2014 Vaccine Industry Excellence Award for "Best Prophylactic Vaccine"

Sanaria received the 2014 Vaccine Industry Excellence Award for the "Best Prophylactic Vaccine" at a ceremony held March 25 in Washington DC during the 14th World Vaccine Congress.

3 Apr 2014

CMC Biologics wins Life Science Leader CMO Leadership award for highest standards of quality, reliability

CMC Biologics, a leading global contract manufacturing organization known for technical excellence and customer satisfaction in biopharmaceutical development and commercial manufacture of protein based therapeutics, was recognized again in 2014 for innovation, quality and reliability by Life Science Leader at an awards ceremony at DCAT Week14 in New York last month.

3 Apr 2014

New evidence indicates another risk factor for young adults consuming energy drinks

Newfound evidence indicates another risk factor for young adults consuming energy drinks. A research team representing six American universities found that the frequency of energy drink use is associated with increased odds of illicit prescription stimulant medication use.

3 Apr 2014

Actavis opens new regional headquarters in Singapore

Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced the official opening of its new regional office in Singapore that will serve as the headquarters for the Company's Asia Pacific and Africa (APACA) region.

3 Apr 2014

Thorne Research launches NiaCel that supports endurance, energy and healthy aging

Thorne Research today announced the launch of NiaCel™, an innovative nutritional supplement that supports endurance, energy, and healthy aging.

2 Apr 2014

EnVivo Pharmaceuticals changes its name to FORUM Pharmaceuticals

EnVivo Pharmaceuticals, Inc. announced today that the company has changed its name to FORUM Pharmaceuticals Inc. The new name better reflects the company's strong position as a late-stage, purpose-built organization that is focused on conquering challenging brain diseases such as schizophrenia and Alzheimer's disease.

2 Apr 2014

AB Sciex launches immunosuppressants kit to improve health care

Every organ transplant patient in the world faces the potential danger of his/her body rejecting a new organ, such as a heart, kidney or liver. Immunosuppressant drugs are required to help prevent rejection.

2 Apr 2014

BioAlliance Pharma, Daewoong sign new licensing agreement for commercialization of Sitavig in South Korea

BioAlliance Pharma SA, an innovative Company specialized in the development of drugs in orphan oncology diseases, today announces an exclusive supply and license agreement for Sitavig® (Acyclovir Lauriad®) with Daewoong Pharmaceutical Co., Ltd. for commercialization rights in South Korea.

2 Apr 2014

Viewpoints: 'Thrice-buried' Obamacare 'looks very much alive;' Ted Cruz 'gets an earful'

Back when rate shock, website problems and lagging enrollment were threatening to unravel the new health care law before it fully took effect, I concluded a column on Obamacare's repeated near-death experiences with the following warning to conservatives: ... What isn't killed outright grows stronger the longer it's embedded in the federal apparatus, gaining constituents and interest-group support just by virtue of its existence even if it doesn't work out the way it was designed. ... the serious right-of-center alternatives to Obamacare have always included policies to expand coverage, and with a coverage expansion accomplished, Republicans may find themselves effectively forced in a more serious direction. ... wherever they go and whatever they do, they will have to deal with the reality that Obamacare, thrice-buried, looks very much alive (Ross Douthat, 3/31).

2 Apr 2014

FDA grants orphan drug designation to ERYTECH’s lead product for AML treatment

ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that its lead product GRASPA®/ERY-ASP has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML), an aggressive form of blood cancer.

2 Apr 2014

Evotec signs research collaboration and licensing deal with Debiopharm Group

Evotec AG announced today a research collaboration and licensing deal with Debiopharm Group™, Lausanne, Switzerland.

2 Apr 2014

New mechanism uses light to activate drug-delivery inside body

Researchers from the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, in collaboration with materials scientists, engineers and neurobiologists, have discovered a new mechanism for using light to activate drug-delivering nanoparticles and other targeted therapeutic substances inside the body.

2 Apr 2014

Northwestern University awarded NIH grant to conduct phase III Parkinson's neuroprotective study

Tanya Simuni, M.D., medical director of Northwestern University's Parkinson's Disease and Movement Disorders Center, was awarded a grant from the National Institutes of Health to conduct a $16 million phase III study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson's disease.

2 Apr 2014

Beckman Coulter Life Sciences’ Avanti centrifuges combine high performance and application versatility

Avanti JXN-26 centrifuges from Beckman Coulter offer lab an intuitive interface and advanced data management features.

From Beckman Coulter Life Sciences - Centrifugation 1 Apr 2014

Discovery could lead to new therapies for people with celiac disease

Researchers at McMaster University have discovered a key molecule that could lead to new therapies for people with celiac disease, an often painful and currently untreatable autoimmune disorder.

1 Apr 2014

Pharmaceuticals News and Research

Auxogyn signs exclusive license agreement with Merck Serono for Eeva Test

Europe's pharmaceutical research community to convene at PRO & eCOA Congress

BIO and WLSA to explore intersection between digital health and biotechnology at 2014 BIO International Convention

Gilead reports topline results from sofosbuvir Phase 3 trial in Japan for treatment of HCV infection

FDA grants Fast Track designations for IV and oral formulations of Tetraphase's eravacycline

Sanaria receives 2014 Vaccine Industry Excellence Award for "Best Prophylactic Vaccine"

CMC Biologics wins Life Science Leader CMO Leadership award for highest standards of quality, reliability

New evidence indicates another risk factor for young adults consuming energy drinks

Actavis opens new regional headquarters in Singapore

Thorne Research launches NiaCel that supports endurance, energy and healthy aging

EnVivo Pharmaceuticals changes its name to FORUM Pharmaceuticals

AB Sciex launches immunosuppressants kit to improve health care

BioAlliance Pharma, Daewoong sign new licensing agreement for commercialization of Sitavig in South Korea

Viewpoints: 'Thrice-buried' Obamacare 'looks very much alive;' Ted Cruz 'gets an earful'

FDA grants orphan drug designation to ERYTECH’s lead product for AML treatment

Evotec signs research collaboration and licensing deal with Debiopharm Group

New mechanism uses light to activate drug-delivery inside body

Northwestern University awarded NIH grant to conduct phase III Parkinson's neuroprotective study

Beckman Coulter Life Sciences’ Avanti centrifuges combine high performance and application versatility

Discovery could lead to new therapies for people with celiac disease

Pittcon Highlights: Pharmaceutical & Biologic eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence